ATIC recently invited members of the type 1 diabetes community to learn more about us – the first Australasian clinical trial collaborative set up to accelerate development and delivery of immunotherapy treatments for people with type 1 diabetes.

During this online (Zoom) Forum, attendees learned about:

• The latest ATIC clinical trial – now recruiting (visit atic.svi.edu.au/clinical-trials for more information)
• Immunotherapy – what is it and how does it work?
• ATIC – how and why it was established
• A participant’s perspective of the clinical trial experience

Host: Dr Michelle So, endocrinologist, researcher, and Lead, ATIC Education & Training Domain.

Panel participants:

• Professor Tom Kay, ATIC Chair
• A/Professor John Wentworth, ATIC Clinical Lead Investigator
• Dr Dorota Pawlak, Chief Scientific Officer, JDRF
• Ms Fiona McGregor, Deputy Chair, ATIC Community Engagement Panel
• Ms Kate Wilkinson, Type 1 diabetes clinical trial participant

You can view the video of the webinar here:

We are also documenting the Qs and As from the event, and will make those available soon.

Follow us on our socials: Facebook, Twitter, LinkedIn.